Newnex
Get Access

Platform

Syndication and co-investment for institutional venture capital.

Direct, peer to peer. No SPV. Private by default. Invite only.

We understand institutional investing. Newnex is built around it.

The network

Live

60+

institutional investors syndicating and co-investing on Newnex.

Principles

  1. 01

    Syndicate and refer follow-on rounds between GPs. Invite your LPs to co-invest.

    GPs syndicate fundraises and follow-on rounds with peer GPs. Invite your own LPs into deals you're leading.

  2. 02

    LPs refer funds to LPs and co-invest.

    LPs refer fund managers to peer LPs and co-invest in deals run by their managers. Allocator-to-allocator, direct.

  3. 03

    Deals work via peer reference.

    Every deal is referred from a member's portfolio or active investments. No scanning, no screening, no algorithmic matching. You bring the deal, we're the channel.

  4. 04

    Global institutional VC network that compounds.

    Invite peer VCs into the network. Discover institutional GPs across geographies by investment strategy. Built on mutual trust between institutional investors.

How VCs Use Newnex

Three ways to syndicate and co-invest with verified institutional investors.

Expand the network. Start a conversation.

Browse the verified network by strategy, stage, and geography. Send a private message, build the peer relationship first, and invite them to view a deal when the time is right.

  1. 1

    Browse Network

    Discover VCs by sector, stage, and geography

  2. 2

    Send Message

    Introduce yourself and start a private conversation

  3. 3

    Build Trust

    Exchange ideas, share views, find common ground

  4. 4

    Share When Ready

    Invite them to view your deal at the right moment

newnex.io

Maria L. · Alpine Ventures

Hi - saw your profile. We're actively looking at climate tech in Europe. Would love to connect.

You

Thanks Maria! We have a Series A climate deal that might be a fit. Happy to share more details.

Maria L. · Alpine Ventures

Sounds interesting. Could you share the deck when ready?
Type a message...Send

Who it's for

What each tier does here

  • For VCs

    Discover other GPs by strategy. Syndicate a fundraise. Forward deals you're passing.

  • For LPs

    Reference and invest in funds through LP references. Co-invest with your GPs.

  • For Founders

    Reach institutional VCs through warm references from your VC contacts.

From the network

Feed

View All

Team S

@newnexteam

Propsoch Raises $2M Seed Funding to Expand Homebuyer Advisory Platform Across India

Bengaluru-based proptech startup Propsoch has secured $2 million in seed funding to accelerate the growth of its homebuyer advisory platform, helping consumers make more informed real estate decisions through data-driven insights and unbiased property analysis. The round was led

Team S

@newnexteam

701x Raises $10M+ Series B to Expand Smart Cattle Technology and Global Operations

North Dakota-based agri-tech startup 701x has closed an oversubscribed Series B funding round exceeding $10 million, backed entirely by ranchers, customers, and local investors-with no venture capital or institutional participation. Founded by Kevin Biffert, 701x has built a

Team S

@newnexteam

StockGro Raises ₹150 Crore Series B to Expand AI-Powered Investing and Financial Education Platform

Bengaluru-based fintech startup StockGro has secured ₹150 crore in Series B funding to accelerate growth of its AI-driven investment platform, expand into new markets, and strengthen its product offerings across multiple asset classes. The round was led by renowned investor

Team S

@newnexteam

Forage Raises $40M Series B to Expand SNAP Payments Infrastructure for Grocery Retailers

Fintech startup Forage has secured $40 million in Series B funding to accelerate the modernization of SNAP (Supplemental Nutrition Assistance Program) payments and expand access to digital grocery commerce for millions of Americans. The round was led by Mouro Capital and values

Team S

@newnexteam

Waypoint Bio Raises $20M Series A to Advance AI-Designed Cell Therapies for Solid Tumors

New York-based biotechnology startup Waypoint Bio has secured $20 million in Series A funding to accelerate the development of AI-designed cell therapies for solid tumors and advance multiple programs into clinical trials. The round was led by Amplify Partners, with

Team S

@newnexteam

Tavo Biotherapeutics Raises $17M Series A to Advance Novel Treatments for Glaucoma and Retinal Diseases

Tavo Biotherapeutics has secured $17 million in Series A financing to accelerate the development of innovative therapies targeting glaucoma and retinal diseases, two of the leading causes of vision loss worldwide. The funding will support the advancement of TAV-001, the

Editorial

News and Views

View All

The network

Investors work privately and confidentially together.

View network

Membership

Join Newnex.

Institutional focused. Invite only. Private by default.

Request invite